TNYATenaya Therapeutics, Inc.
- Market cap
- $87.23M
- as of 2026-10-23
- Latest close
- $0.39
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-02-14
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Tingley WhittemoreChief Medical Officer | Sep 10 | Sep 11 | A | 49,000 | $0.00 | $0 | 263,073 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Sep 10 | Sep 11 | A · derivative | 293,000 | $0.65 | $190,450 | 293,000 | No | Form 4 |
| Ali FarazChief Executive Officer | Sep 10 | Sep 11 | A | 122,000 | $0.00 | $0 | 539,782 | No | Form 4 |
| Ali FarazChief Executive Officer | Sep 10 | Sep 11 | A · derivative | 732,500 | $0.65 | $476,125 | 732,500 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Aug 17 | Aug 17 | S | 1,637 | $0.71 | Sale −$1,162 | 219,860 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Aug 17 | Aug 17 | S | 1,637 | $0.71 | Sale −$1,162 | 218,223 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Aug 17 | Aug 17 | S | 1,871 | $0.71 | Sale −$1,328 | 216,352 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Aug 17 | Aug 17 | S | 2,279 | $0.71 | Sale −$1,618 | 214,073 | No | Form 4 |
| Ali FarazChief Executive Officer | Aug 17 | Aug 17 | S | 5,837 | $0.71 | Sale −$4,144 | 434,177 | No | Form 4 |
| Ali FarazChief Executive Officer | Aug 17 | Aug 17 | S | 3,969 | $0.71 | Sale −$2,818 | 430,208 | No | Form 4 |
| Ali FarazChief Executive Officer | Aug 17 | Aug 17 | S | 5,020 | $0.71 | Sale −$3,564 | 425,188 | No | Form 4 |
| Ali FarazChief Executive Officer | Aug 17 | Aug 17 | S | 7,406 | $0.71 | Sale −$5,258 | 417,782 | No | Form 4 |
| Hyllengren Eric JChief Financial Officer | Jul 13 | Jul 14 | A · derivative | 1,650,000 | $0.84 | $1,386,000 | 1,650,000 | No | Form 4 |
| Burroughs Amy L. | May 28 | May 29 | A · derivative | 120,000 | $0.80 | $96,000 | 120,000 | No | Form 4 |
| Lee June | May 28 | May 29 | A · derivative | 120,000 | $0.80 | $96,000 | 120,000 | No | Form 4 |
| Parschauer Karah Herdman | May 28 | May 29 | A · derivative | 120,000 | $0.80 | $96,000 | 120,000 | No | Form 4 |
| Srivastava Deepak | May 28 | May 29 | A · derivative | 120,000 | $0.80 | $96,000 | 120,000 | No | Form 4 |
| Stehman-Breen Catherine | May 28 | May 29 | A · derivative | 120,000 | $0.80 | $96,000 | 120,000 | No | Form 4 |
| Walsh Jeffrey T. | May 28 | May 29 | A · derivative | 120,000 | $0.80 | $96,000 | 120,000 | No | Form 4 |
| Williams R Sanders | May 28 | May 29 | A · derivative | 120,000 | $0.80 | $96,000 | 120,000 | No | Form 4 |
| Higa TomohiroSVP, Finance | May 18 | May 19 | S | 1,485 | $0.79 | Sale −$1,173 | 118,267 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | May 18 | May 19 | S | 3,121 | $0.79 | Sale −$2,466 | 215,497 | No | Form 4 |
| Ali FarazChief Executive Officer | May 18 | May 19 | S | 3,390 | $0.79 | Sale −$2,678 | 440,014 | No | Form 4 |
| TCG Opportunity III GP, LLC | Feb 25 | Feb 26 | S | 1,649,281 | $0.56 | Sale −$923,597 | not reported | No | Form 4 |
| TCG Opportunity III GP, LLC | Feb 25 | Feb 26 | S | 1,862,545 | $0.56 | Sale −$1,043,025 | not reported | No | Form 4 |
| TCG Opportunity III GP, LLC | Feb 24 | Feb 26 | S | 309,228 | $0.62 | Sale −$191,721 | 1,649,281 | No | Form 4 |
| TCG Opportunity III GP, LLC | Feb 24 | Feb 26 | S | 349,212 | $0.62 | Sale −$216,511 | 1,862,545 | No | Form 4 |
| Column Group Iii-A, LP | Feb 23 | Feb 24 | S | 143,709 | $0.60 | Sale −$86,225 | 1,958,509 | No | Form 4 |
| Column Group Iii-A, LP | Feb 23 | Feb 24 | S | 162,291 | $0.60 | Sale −$97,375 | 2,211,757 | No | Form 4 |
| Column Group Iii-A, LP | Feb 20 | Feb 24 | S | 245,965 | $0.61 | Sale −$150,039 | 2,102,218 | No | Form 4 |
| Column Group Iii-A, LP | Feb 20 | Feb 24 | S | 277,769 | $0.61 | Sale −$169,439 | 2,374,048 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Feb 17 | Feb 17 | S | 1,642 | $0.64 | Sale −$1,051 | 222,136 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Feb 17 | Feb 17 | S | 1,642 | $0.64 | Sale −$1,051 | 220,494 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Feb 17 | Feb 17 | S | 1,876 | $0.64 | Sale −$1,201 | 218,618 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 17 | Feb 17 | S | 5,851 | $0.64 | Sale −$3,745 | 452,415 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 17 | Feb 17 | S | 3,979 | $0.64 | Sale −$2,547 | 448,436 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 17 | Feb 17 | S | 5,032 | $0.64 | Sale −$3,220 | 443,404 | No | Form 4 |
| Higa TomohiroSVP, Finance | Feb 17 | Feb 17 | S | 611 | $0.64 | Sale −$391 | 122,610 | No | Form 4 |
| Higa TomohiroSVP, Finance | Feb 17 | Feb 17 | S | 836 | $0.64 | Sale −$535 | 121,774 | No | Form 4 |
| Higa TomohiroSVP, Finance | Feb 17 | Feb 17 | S | 2,022 | $0.64 | Sale −$1,294 | 119,752 | No | Form 4 |
| Column Group Iii-A, LP | Feb 11 | Feb 12 | S | 1,905,115 | $0.68 | Sale −$1,295,478 | 2,348,183 | No | Form 4 |
| Column Group Iii-A, LP | Feb 11 | Feb 12 | S | 2,151,458 | $0.68 | Sale −$1,462,991 | 2,651,817 | No | Form 4 |
| Column Group Iii-A, LP | Feb 10 | Feb 12 | S | 161,422 | $0.82 | Sale −$132,366 | 4,253,298 | No | Form 4 |
| Column Group Iii-A, LP | Feb 10 | Feb 12 | S | 182,295 | $0.82 | Sale −$149,482 | 4,803,275 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 3 | Feb 5 | A | 158,600 | $0.00 | $0 | 458,266 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 3 | Feb 5 | A · derivative | 952,250 | $0.92 | $876,070 | 952,250 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Feb 3 | Feb 5 | A | 48,750 | $0.00 | $0 | 223,778 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Feb 3 | Feb 5 | A · derivative | 318,500 | $0.92 | $293,020 | 318,500 | No | Form 4 |
| Higa TomohiroSVP, Finance | Feb 3 | Feb 5 | A | 29,250 | $0.00 | $0 | 123,221 | No | Form 4 |
| Higa TomohiroSVP, Finance | Feb 3 | Feb 5 | A · derivative | 175,500 | $0.92 | $161,460 | 175,500 | No | Form 4 |
| Ali FarazChief Executive Officer | Nov 17, 2025 | Nov 17, 2025 | S | 3,126 | $1.33 | Sale −$4,158 | 299,666 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Nov 17, 2025 | Nov 17, 2025 | S | 2,877 | $1.33 | Sale −$3,826 | 169,926 | No | Form 4 |
| Higa TomohiroSVP, Finance | Nov 17, 2025 | Nov 17, 2025 | S | 1,367 | $1.33 | Sale −$1,818 | 93,971 | No | Form 4 |
| Higa TomohiroSVP, Finance | Aug 18, 2025 | Aug 18, 2025 | S | 523 | $1.25 | Sale −$654 | 97,777 | No | Form 4 |
| Higa TomohiroSVP, Finance | Aug 18, 2025 | Aug 18, 2025 | S | 717 | $1.25 | Sale −$896 | 97,060 | No | Form 4 |
| Higa TomohiroSVP, Finance | Aug 18, 2025 | Aug 18, 2025 | S | 1,722 | $1.25 | Sale −$2,153 | 95,338 | No | Form 4 |
| Ali FarazChief Executive Officer | Aug 18, 2025 | Aug 18, 2025 | S | 5,720 | $1.25 | Sale −$7,150 | 311,605 | No | Form 4 |
| Ali FarazChief Executive Officer | Aug 18, 2025 | Aug 18, 2025 | S | 3,893 | $1.25 | Sale −$4,866 | 307,712 | No | Form 4 |
| Ali FarazChief Executive Officer | Aug 18, 2025 | Aug 18, 2025 | S | 4,920 | $1.25 | Sale −$6,150 | 302,792 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Aug 18, 2025 | Aug 18, 2025 | S | 1,608 | $1.25 | Sale −$2,010 | 176,248 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Aug 18, 2025 | Aug 18, 2025 | S | 1,608 | $1.25 | Sale −$2,010 | 174,640 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Aug 18, 2025 | Aug 18, 2025 | S | 1,837 | $1.25 | Sale −$2,296 | 172,803 | No | Form 4 |
| Parschauer Karah Herdman | May 29, 2025 | May 30, 2025 | A · derivative | 107,400 | $0.44 | $47,256 | 107,400 | No | Form 4 |
| Lee June | May 29, 2025 | May 30, 2025 | A · derivative | 107,400 | $0.44 | $47,256 | 107,400 | No | Form 4 |
| Srivastava Deepak | May 29, 2025 | May 30, 2025 | A · derivative | 107,400 | $0.44 | $47,256 | 107,400 | No | Form 4 |
| Williams R Sanders | May 29, 2025 | May 30, 2025 | A · derivative | 107,400 | $0.44 | $47,256 | 107,400 | No | Form 4 |
| Goeddel David V | May 29, 2025 | May 30, 2025 | A · derivative | 107,400 | $0.44 | $47,256 | 107,400 | No | Form 4 |
| Burroughs Amy L. | May 29, 2025 | May 30, 2025 | A · derivative | 107,400 | $0.44 | $47,256 | 107,400 | No | Form 4 |
| Walsh Jeffrey T. | May 29, 2025 | May 30, 2025 | A · derivative | 107,400 | $0.44 | $47,256 | 107,400 | No | Form 4 |
| Stehman-Breen Catherine | May 29, 2025 | May 30, 2025 | A · derivative | 107,400 | $0.44 | $47,256 | 107,400 | No | Form 4 |
| Ali FarazChief Executive Officer | May 16, 2025 | May 16, 2025 | S | 3,189 | $0.44 | Sale −$1,403 | 317,325 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | May 16, 2025 | May 16, 2025 | S | 2,937 | $0.44 | Sale −$1,292 | 171,856 | No | Form 4 |
| Higa TomohiroSVP, Finance | May 16, 2025 | May 16, 2025 | S | 1,390 | $0.44 | Sale −$612 | 98,300 | No | Form 4 |
| Ali FarazChief Executive Officer | Mar 10, 2025 | Mar 10, 2025 | S | 5,794 | $0.54 | Sale −$3,129 | 324,461 | No | Form 4 |
| Ali FarazChief Executive Officer | Mar 10, 2025 | Mar 10, 2025 | S | 3,947 | $0.54 | Sale −$2,131 | 320,514 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Mar 10, 2025 | Mar 10, 2025 | S | 1,727 | $0.54 | Sale −$933 | 180,464 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Mar 10, 2025 | Mar 10, 2025 | S | 4,073 | $0.54 | Sale −$2,199 | 176,391 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Mar 10, 2025 | Mar 10, 2025 | S | 1,598 | $0.54 | Sale −$863 | 174,793 | No | Form 4 |
| Higa TomohiroSVP, Finance | Mar 10, 2025 | Mar 10, 2025 | S | 1,017 | $0.54 | Sale −$549 | 101,155 | No | Form 4 |
| Higa TomohiroSVP, Finance | Mar 10, 2025 | Mar 10, 2025 | S | 620 | $0.54 | Sale −$335 | 100,535 | No | Form 4 |
| Higa TomohiroSVP, Finance | Mar 10, 2025 | Mar 10, 2025 | S | 845 | $0.54 | Sale −$456 | 99,690 | No | Form 4 |
| Goeddel David V | Mar 5, 2025 | Mar 7, 2025 | P | 35,714,284 | $0.70 | Purchase +$24,999,999 | 49,313,559 | No | Form 4 |
| Goeddel David V | Mar 5, 2025 | Mar 7, 2025 | P · derivative | 35,714,284 | $0.80 | Purchase +$28,571,427 | 35,714,284 | No | Form 4 |
| Goeddel David V | Mar 5, 2025 | Mar 7, 2025 | P · derivative | 17,857,142 | $0.70 | Purchase +$12,499,999 | 17,857,142 | No | Form 4 |
| Column Group III, LP | Mar 5, 2025 | Mar 7, 2025 | P | 35,714,284 | $0.70 | Purchase +$24,999,999 | 49,313,559 | No | Form 4 |
| Column Group III, LP | Mar 5, 2025 | Mar 7, 2025 | P · derivative | 35,714,284 | $0.80 | Purchase +$28,571,427 | 35,714,284 | No | Form 4 |
| Column Group III, LP | Mar 5, 2025 | Mar 7, 2025 | P · derivative | 17,857,142 | $0.70 | Purchase +$12,499,999 | 17,857,142 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 6, 2025 | Feb 7, 2025 | A | 107,500 | $0.00 | $0 | 295,831 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 6, 2025 | Feb 7, 2025 | A | 34,424 | $0.00 | $0 | 330,255 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 6, 2025 | Feb 7, 2025 | A · derivative | 650,000 | $1.00 | $650,000 | 650,000 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 6, 2025 | Feb 7, 2025 | D · derivative | 353,271 | $5.64 | $1,992,448 | not reported | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 6, 2025 | Feb 7, 2025 | A · derivative | 353,271 | $1.21 | $427,458 | 353,271 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 6, 2025 | Feb 7, 2025 | D · derivative | 161,214 | $9.36 | $1,508,963 | not reported | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 6, 2025 | Feb 7, 2025 | A · derivative | 161,214 | $1.21 | $195,069 | 161,214 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 6, 2025 | Feb 7, 2025 | D · derivative | 401,390 | $15.19 | $6,097,114 | not reported | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 6, 2025 | Feb 7, 2025 | A · derivative | 401,390 | $1.21 | $485,682 | 401,390 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Jan 24, 2025 | Jan 28, 2025 | A | 40,000 | $0.00 | $0 | 147,106 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Jan 24, 2025 | Jan 28, 2025 | A | 31,676 | $0.00 | $0 | 178,782 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Jan 24, 2025 | Jan 28, 2025 | A · derivative | 235,000 | $1.21 | $284,350 | 235,000 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Jan 24, 2025 | Jan 28, 2025 | D · derivative | 69,982 | $9.36 | $655,032 | not reported | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Jan 24, 2025 | Jan 28, 2025 | A · derivative | 69,982 | $1.21 | $84,678 | 69,982 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Jan 24, 2025 | Jan 28, 2025 | D · derivative | 141,000 | $15.19 | $2,141,790 | not reported | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Jan 24, 2025 | Jan 28, 2025 | A · derivative | 141,000 | $1.21 | $170,610 | 141,000 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Jan 24, 2025 | Jan 28, 2025 | D · derivative | 205,000 | $3.06 | $627,300 | not reported | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Jan 24, 2025 | Jan 28, 2025 | A · derivative | 205,000 | $1.21 | $248,050 | 205,000 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Jan 24, 2025 | Jan 28, 2025 | D · derivative | 215,000 | $5.22 | $1,122,300 | not reported | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Jan 24, 2025 | Jan 28, 2025 | A · derivative | 215,000 | $1.21 | $260,150 | 215,000 | No | Form 4 |
| Saito ChihiroSVP, Accounting and Fin. Ops. | Nov 18, 2024 | Nov 18, 2024 | S | 2,258 | $2.12 | Sale −$4,787 | 60,983 | No | Form 4 |
| Burroughs Amy L. | Oct 18, 2024 | Oct 21, 2024 | A · derivative | 34,000 | $2.04 | $69,360 | 34,000 | No | Form 4 |
| Goeddel David V | Oct 18, 2024 | Oct 21, 2024 | A · derivative | 34,000 | $2.04 | $69,360 | 34,000 | No | Form 4 |
| Lee June | Oct 18, 2024 | Oct 21, 2024 | A · derivative | 34,000 | $2.04 | $69,360 | 34,000 | No | Form 4 |
| Parschauer Karah Herdman | Oct 18, 2024 | Oct 21, 2024 | A · derivative | 34,000 | $2.04 | $69,360 | 34,000 | No | Form 4 |
| Srivastava Deepak | Oct 18, 2024 | Oct 21, 2024 | A · derivative | 34,000 | $2.04 | $69,360 | 34,000 | No | Form 4 |
| Stehman-Breen Catherine | Oct 18, 2024 | Oct 21, 2024 | A · derivative | 34,000 | $2.04 | $69,360 | 34,000 | No | Form 4 |
| Williams R Sanders | Oct 18, 2024 | Oct 21, 2024 | A · derivative | 34,000 | $2.04 | $69,360 | 34,000 | No | Form 4 |
| Walsh Jeffrey T. | Oct 18, 2024 | Oct 21, 2024 | A · derivative | 34,000 | $2.04 | $69,360 | 34,000 | No | Form 4 |
| Saito ChihiroSVP, Accounting and Fin. Ops. | Aug 16, 2024 | Aug 19, 2024 | S | 902 | $2.89 | Sale −$2,607 | 64,702 | No | Form 4 |
| Saito ChihiroSVP, Accounting and Fin. Ops. | Aug 16, 2024 | Aug 19, 2024 | S | 654 | $2.89 | Sale −$1,890 | 64,048 | No | Form 4 |
| Saito ChihiroSVP, Accounting and Fin. Ops. | Aug 16, 2024 | Aug 19, 2024 | S | 807 | $2.89 | Sale −$2,332 | 63,241 | No | Form 4 |
| Saito ChihiroSVP, Accounting and Fin. Ops. | Aug 15, 2024 | Aug 19, 2024 | A | 25,000 | $0.00 | $0 | 65,604 | No | Form 4 |
| Ali FarazChief Executive Officer | Aug 16, 2024 | Aug 16, 2024 | S | 5,802 | $2.89 | Sale −$16,768 | 192,277 | No | Form 4 |
| Ali FarazChief Executive Officer | Aug 16, 2024 | Aug 16, 2024 | S | 3,946 | $2.89 | Sale −$11,404 | 188,331 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Aug 16, 2024 | Aug 16, 2024 | S | 5,803 | $2.89 | Sale −$16,771 | 108,731 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Aug 16, 2024 | Aug 16, 2024 | S | 1,625 | $2.89 | Sale −$4,696 | 107,106 | No | Form 4 |
| Hoey TimothyChief Scientific Officer | Mar 5, 2024 | Mar 6, 2024 | S | 3,300 | $7.00 | Sale −$23,100 | 245,346 | Yes | Form 4 |
| Ali FarazChief Executive Officer | Feb 23, 2024 | Feb 27, 2024 | A | 85,000 | $0.00 | $0 | 198,079 | No | Form 4 |
| Ali FarazChief Executive Officer | Feb 23, 2024 | Feb 27, 2024 | A · derivative | 505,000 | $5.22 | $2,636,100 | 505,000 | No | Form 4 |
| Patterson Leone DChief Fin. and Bus. Officer | Feb 23, 2024 | Feb 27, 2024 | A | 35,000 | $0.00 | $0 | 95,755 | No | Form 4 |
| Patterson Leone DChief Fin. and Bus. Officer | Feb 23, 2024 | Feb 27, 2024 | A · derivative | 205,000 | $5.22 | $1,070,100 | 205,000 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Feb 23, 2024 | Feb 27, 2024 | A | 35,000 | $0.00 | $0 | 108,534 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Feb 23, 2024 | Feb 27, 2024 | A · derivative | 215,000 | $5.22 | $1,122,300 | 215,000 | No | Form 4 |
| Hoey TimothyChief Scientific Officer | Feb 23, 2024 | Feb 27, 2024 | A | 12,500 | $0.00 | $0 | 248,646 | No | Form 4 |
| Hoey TimothyChief Scientific Officer | Feb 23, 2024 | Feb 27, 2024 | A · derivative | 75,000 | $5.22 | $391,500 | 75,000 | No | Form 4 |
| Hoey TimothyChief Scientific Officer | Feb 20, 2024 | Feb 21, 2024 | S | 6,369 | $5.31 | Sale −$33,819 | 236,346 | Yes | Form 4 |
| Hoey TimothyChief Scientific Officer | Feb 20, 2024 | Feb 21, 2024 | S | 200 | $6.17 | Sale −$1,234 | 236,146 | Yes | Form 4 |
| Ali FarazChief Executive Officer | Feb 16, 2024 | Feb 16, 2024 | S | 6,358 | $5.86 | Sale −$37,258 | 113,079 | No | Form 4 |
| Patterson Leone DChief Fin. and Bus. Officer | Feb 16, 2024 | Feb 16, 2024 | S | 5,201 | $5.86 | Sale −$30,478 | 60,755 | No | Form 4 |
| Tingley WhittemoreChief Medical Officer | Feb 16, 2024 | Feb 16, 2024 | S | 6,500 | $5.86 | Sale −$38,090 | 73,534 | No | Form 4 |
| Hoey TimothyChief Scientific Officer | Feb 16, 2024 | Feb 16, 2024 | S | 4,681 | $5.86 | Sale −$27,431 | 242,715 | No | Form 4 |
| Goeddel David V | Feb 12, 2024 | Feb 14, 2024 | P | 2,222,222 | $4.50 | Purchase +$9,999,999 | 13,599,275 | No | Form 4 |
| Column Group Iii-A, LP | Feb 12, 2024 | Feb 14, 2024 | P | 2,222,222 | $4.50 | Purchase +$9,999,999 | 13,599,275 | No | Form 4 |